Agios Pharmaceuticals | AGIO - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.22B 329M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 4.5B 194M 2025-12
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Exelixis USD 26.48M 7.91M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12